Paper36950301
High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy.
Bousquet E and 11 others. Ophthalmol Sci, 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy. Papers, record 36950301. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36950301
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33214636 | Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy. | Sci Rep | 2020 | https://conductscience.org/library/papers/33214636 | PubMed |
| 2 | 19188531 | Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. | Psychosom Med | 2009 | https://conductscience.org/library/papers/19188531 | PubMed |
| 3 | 35833423 | Corticotroph isolation from Pomc-eGFP mice reveals sustained transcriptional dysregulation characterising a mouse model of glucocorticoid-induced suppression of the hypothalamus-pituitary-adrenal axis. | J Neuroendocrinol | 2022 | https://conductscience.org/library/papers/35833423 | PubMed |
| 4 | 25552549 | Glucocorticoid augments lipopolysaccharide-induced activation of the IκBζ-dependent genes encoding the anti-microbial glycoproteins lipocalin 2 and pentraxin 3. | J Biochem | 2015 | https://conductscience.org/library/papers/25552549 | PubMed |
| 5 | 18703503 | Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18703503 | PubMed |
| 6 | 9079634 | Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9079634 | PubMed |
| 7 | 25227506 | One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids. | Neuroimmunomodulation | 2015 | https://conductscience.org/library/papers/25227506 | PubMed |
| 8 | 34029721 | Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders. | Prog Retin Eye Res | 2022 | https://conductscience.org/library/papers/34029721 | PubMed |
| 9 | 34877649 | Mineralocorticoid pathway in retinal health and diseases. | Br J Pharmacol | 2022 | https://conductscience.org/library/papers/34877649 | PubMed |
| 10 | 27659908 | Pentraxin 3 recruits complement factor H to protect against oxidative stress-induced complement and inflammasome overactivation. | J Pathol | 2016 | https://conductscience.org/library/papers/27659908 | PubMed |
| 11 | 26026923 | Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. | Prog Retin Eye Res | 2015 | https://conductscience.org/library/papers/26026923 | PubMed |
| 12 | 28489776 | Is C-reactive protein a marker of obstructive sleep apnea?: A meta-analysis. | Medicine (Baltimore) | 2017 | https://conductscience.org/library/papers/28489776 | PubMed |
| 13 | 32317461 | Monocyte to high-density lipoprotein and neutrophil-to-lymphocyte ratios in patients with acute central serous chorioretinopathy. | Indian J Ophthalmol | 2020 | https://conductscience.org/library/papers/32317461 | PubMed |
| 14 | 28814876 | Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy. | Ther Clin Risk Manag | 2017 | https://conductscience.org/library/papers/28814876 | PubMed |
| 15 | 34669028 | Validation of central serous chorioretinopathy multimodal imaging-based classification system. | Graefes Arch Clin Exp Ophthalmol | 2022 | https://conductscience.org/library/papers/34669028 | PubMed |
| 16 | 25159210 | Elevated plasma pentraxin 3 levels are associated with development and progression of diabetic retinopathy in Korean patients with type 2 diabetes mellitus. | Invest Ophthalmol Vis Sci | 2014 | https://conductscience.org/library/papers/25159210 | PubMed |
| 17 | 19968561 | An integrated view of humoral innate immunity: pentraxins as a paradigm. | Annu Rev Immunol | 2010 | https://conductscience.org/library/papers/19968561 | PubMed |
| 18 | 24654791 | Elevated Plasma Pentraxin3 Levels and Its Association with Neovascular Age-related Macular Degeneration. | Ocul Immunol Inflamm | 2015 | https://conductscience.org/library/papers/24654791 | PubMed |
| 19 | 32407978 | Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities. | Prog Retin Eye Res | 2020 | https://conductscience.org/library/papers/32407978 | PubMed |
| 20 | 27105755 | Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review. | Semin Arthritis Rheum | 2016 | https://conductscience.org/library/papers/27105755 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42233726 | Steroidome Dysregulation and Complement C4 Copy Number Variation in Men With Central Serous Chorioretinopathy. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42233726 | PubMed |
| 41325540 | Systemic C-reactive protein levels and central serous chorioretinopathy: A systematic review with meta-analysis. | Acta Ophthalmol | 2026 | https://conductscience.org/library/papers/41325540 | PubMed |
| 41191121 | Pentraxin-3 and Lipocalin-2 are decreased in patients with uveal effusion syndrome. | Int Ophthalmol | 2025 | https://conductscience.org/library/papers/41191121 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36950301
GET https://conductscience.org/api/papers/v1/36950301/references?page=2